Annual CFF
$14.85 M
-$62.38 M-80.77%
December 31, 2023
Summary
- As of February 7, 2025, SCPH annual cash flow from financing activities is $14.85 million, with the most recent change of -$62.38 million (-80.77%) on December 31, 2023.
- During the last 3 years, SCPH annual CFF has fallen by -$45.50 million (-75.39%).
- SCPH annual CFF is now -85.45% below its all-time high of $102.07 million, reached on December 31, 2017.
Performance
SCPH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$70.41 M
+$70.13 M+24780.92%
September 30, 2024
Summary
- As of February 7, 2025, SCPH quarterly cash flow from financing activities is $70.41 million, with the most recent change of +$70.13 million (+24780.92%) on September 30, 2024.
- Over the past year, SCPH quarterly CFF has increased by +$69.95 million (+14977.73%).
- SCPH quarterly CFF is now -23.80% below its all-time high of $92.41 million, reached on December 31, 2017.
Performance
SCPH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$71.18 M
+$70.34 M+8444.78%
September 30, 2024
Summary
- As of February 7, 2025, SCPH TTM cash flow from financing activities is $71.18 million, with the most recent change of +$70.34 million (+8444.78%) on September 30, 2024.
- Over the past year, SCPH TTM CFF has increased by +$56.33 million (+379.31%).
- SCPH TTM CFF is now -30.31% below its all-time high of $102.14 million, reached on March 31, 2018.
Performance
SCPH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SCPH Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.8% | +10000.0% | +379.3% |
| 3 y3 years | -75.4% | -16.8% | -7.8% |
| 5 y5 years | +10000.0% | -16.8% | -7.8% |
SCPH Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -80.8% | +687.0% | -16.8% | +2940.4% | -28.1% | +824.1% |
| 5 y | 5-year | -80.8% | +687.0% | -16.8% | +2940.4% | -28.1% | +824.1% |
| alltime | all time | -85.5% | +687.0% | -23.8% | +2940.4% | -30.3% | +824.1% |
ScPharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $70.41 M(>+9900.0%) | $71.18 M(+8444.8%) |
| Jun 2024 | - | $283.00 K(+1786.7%) | $833.00 K(-28.3%) |
| Mar 2024 | - | $15.00 K(-96.8%) | $1.16 M(-92.2%) |
| Dec 2023 | $14.85 M(-80.8%) | $467.00 K(+586.8%) | $14.85 M(-85.0%) |
| Sep 2023 | - | $68.00 K(-88.9%) | $98.98 M(+2.6%) |
| Jun 2023 | - | $611.00 K(-95.5%) | $96.44 M(+3.2%) |
| Mar 2023 | - | $13.70 M(-83.8%) | $93.41 M(+21.0%) |
| Dec 2022 | $77.23 M(-3152.5%) | $84.60 M(-3515.5%) | $77.23 M(-885.6%) |
| Sep 2022 | - | -$2.48 M(+2.5%) | -$9.83 M(+33.7%) |
| Jun 2022 | - | -$2.42 M(-2.5%) | -$7.35 M(+48.9%) |
| Mar 2022 | - | -$2.48 M(+0.9%) | -$4.94 M(+95.1%) |
| Dec 2021 | -$2.53 M(-104.2%) | -$2.46 M(<-9900.0%) | -$2.53 M(+4765.4%) |
| Sep 2021 | - | $0.00(0.0%) | -$52.00 K(-61.2%) |
| Jun 2021 | - | $0.00(-100.0%) | -$134.00 K(-100.3%) |
| Mar 2021 | - | -$72.00 K(-460.0%) | $49.82 M(-17.4%) |
| Dec 2020 | $60.35 M | $20.00 K(-124.4%) | $60.35 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$82.00 K(-100.2%) | $64.22 M(-13.2%) |
| Jun 2020 | - | $49.95 M(+377.6%) | $73.98 M(+207.9%) |
| Mar 2020 | - | $10.46 M(+168.4%) | $24.03 M(+76.8%) |
| Dec 2019 | $13.59 M(<-9900.0%) | $3.90 M(-59.7%) | $13.59 M(+41.1%) |
| Sep 2019 | - | $9.67 M(>+9900.0%) | $9.63 M(<-9900.0%) |
| Jun 2019 | - | $0.00(-100.0%) | -$47.00 K(+2.2%) |
| Mar 2019 | - | $18.00 K(-129.5%) | -$46.00 K(+475.0%) |
| Dec 2018 | -$8000.00(-100.0%) | -$61.00 K(+1425.0%) | -$8000.00(-100.0%) |
| Sep 2018 | - | -$4000.00(-500.0%) | $92.46 M(-0.0%) |
| Jun 2018 | - | $1000.00(-98.2%) | $92.46 M(-9.5%) |
| Mar 2018 | - | $56.00 K(-99.9%) | $102.14 M(+0.1%) |
| Dec 2017 | $102.07 M(+92.0%) | $92.41 M(<-9900.0%) | $102.07 M(+956.0%) |
| Sep 2017 | - | -$2000.00(-100.0%) | $9.67 M(-0.0%) |
| Jun 2017 | - | $9.68 M(<-9900.0%) | $9.67 M(<-9900.0%) |
| Mar 2017 | - | -$8000.00 | -$8000.00 |
| Dec 2016 | $53.17 M(+563.3%) | - | - |
| Dec 2015 | $8.02 M | - | - |
FAQ
- What is scPharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for scPharmaceuticals?
- What is scPharmaceuticals annual CFF year-on-year change?
- What is scPharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for scPharmaceuticals?
- What is scPharmaceuticals quarterly CFF year-on-year change?
- What is scPharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for scPharmaceuticals?
- What is scPharmaceuticals TTM CFF year-on-year change?
What is scPharmaceuticals annual cash flow from financing activities?
The current annual CFF of SCPH is $14.85 M
What is the all time high annual CFF for scPharmaceuticals?
scPharmaceuticals all-time high annual cash flow from financing activities is $102.07 M
What is scPharmaceuticals annual CFF year-on-year change?
Over the past year, SCPH annual cash flow from financing activities has changed by -$62.38 M (-80.77%)
What is scPharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of SCPH is $70.41 M
What is the all time high quarterly CFF for scPharmaceuticals?
scPharmaceuticals all-time high quarterly cash flow from financing activities is $92.41 M
What is scPharmaceuticals quarterly CFF year-on-year change?
Over the past year, SCPH quarterly cash flow from financing activities has changed by +$69.95 M (+14977.73%)
What is scPharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of SCPH is $71.18 M
What is the all time high TTM CFF for scPharmaceuticals?
scPharmaceuticals all-time high TTM cash flow from financing activities is $102.14 M
What is scPharmaceuticals TTM CFF year-on-year change?
Over the past year, SCPH TTM cash flow from financing activities has changed by +$56.33 M (+379.31%)